Hematoma Block for Reduction of Distal Radius Fractures

HaEmek Medical Center, Israel

Status and phase: Completed; Phase 4

Conditions: Fractures of the Distal Radius

Treatments: Drug: Lidocaine HCl 1%; Drug: Lidocaine HCl 2% .

Study type: Interventional

Funder types: Other

Identifiers

NCT02129270

158-13-EMC

Details and patient eligibility

About

The purpose of this study is to Prove that injection of 15 to 20 mL of lidocaine 1% into the fracture site (Hematoma block) is more effective in terms of pain relieving then injection of 10 mL of lidocaine 2%, and equally safe in terms of complications, for closed reduction of distal radius fractures.

Enrollment: 24 patients

Sex: All

Ages: 15+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with Fractures of the distal radius, with or without ulna fracture

Exclusion criteria

• Children,
• pregnant women,
• patients with infection or suspected infection on the site for injection.
• Patients whose condition requires general anesthesia (patients with more fractures other than the distal radius and ulna, patients with many damage...)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

24 participants in 2 patient groups

Lidocaine HCl 2%

Active Comparator group

Description:

Lidocaine HCl 2% (200mg/10ml) 10 ml.

Treatment:

Drug: Lidocaine HCl 2% .

Lidocaine HCl 1%

Experimental group

Description:

Lidocaine HCl 1% (100mg/10ml) 15-20 ml.

Treatment:

Drug: Lidocaine HCl 1%